Key Record Dates
ClinicalTrials.gov Identifier: | NCT05327647 |
---|---|
Brief Title: | A Phase II Trial of Bicalutamide in Patients Receiving Intravesical BCG for Non-muscle Invasive Bladder Cancer (BicaBCa) |
First Submitted : | April 7, 2022 |
First Submitted that Met QC Criteria : | April 7, 2022 |
First Posted : | April 14, 2022 |
Last Update Submitted that Met QC Criteria : | February 6, 2024 |
Last Update Posted : | February 7, 2024 |